Literature DB >> 10944471

Surface expression of lactoferrin by resting neutrophils.

L V Deriy1, J Chor, L L Thomas.   

Abstract

We examined the surface expression of lactoferrin by human neutrophils. Western blot analysis with anti-lactoferrin antibodies demonstrated the presence of a 78- to 79-kDa band in plasma membranes isolated from resting neutrophils that corresponded to the 78- to 79-kDa protein in neutrophil secondary granules. Flow cytometry using FITC-conjugated anti-lactoferrin antibodies confirmed that lactoferrin is expressed on the neutrophil surface. Preincubating the neutrophils in acidic (pH 3.9) buffer did not alter staining of the cells by the antibodies. Surface expression of lactoferrin was also detected on neutrophils in whole blood. Neutrophil activation by C5a or the calcium ionophore A23187 did not increase the surface expression of lactoferrin. Instead, the level of lactoferrin expression detected with one of two monoclonal antibodies was diminished after neutrophil activation, suggesting a possible conformational change in the lactoferrin. The surface-expressed lactoferrin may provide a mechanism for the interaction between lactoferrin-binding microorganisms and neutrophils. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10944471     DOI: 10.1006/bbrc.2000.3284

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Both family 1 and family 2 PspA proteins can inhibit complement deposition and confer virulence to a capsular serotype 3 strain of Streptococcus pneumoniae.

Authors:  Bing Ren; Alexander J Szalai; Orlanda Thomas; Susan K Hollingshead; David E Briles
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

2.  Synergistic activity of synthetic N-terminal peptide of human lactoferrin in combination with various antibiotics against carbapenem-resistant Klebsiella pneumoniae strains.

Authors:  P Morici; W Florio; C Rizzato; E Ghelardi; A Tavanti; G M Rossolini; A Lupetti
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-05-03       Impact factor: 3.267

3.  Activation by inflammatory stimuli increases neutrophil binding of human immunodeficiency virus type 1 and subsequent infection of lymphocytes.

Authors:  Ali M Gabali; Joshua J Anzinger; Gregory T Spear; Larry L Thomas
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

4.  The Presence of Anti-Lactoferrin Antibodies in a Subgroup of Eosinophilic Granulomatosis with Polyangiitis Patients and Their Possible Contribution to Enhancement of Neutrophil Extracellular Trap Formation.

Authors:  Haruki Shida; Daigo Nakazawa; Yu Tateyama; Arina Miyoshi; Yoshihiro Kusunoki; Fumihiko Hattanda; Sakiko Masuda; Utano Tomaru; Tamihiro Kawakami; Tatsuya Atsumi; Akihiro Ishizu
Journal:  Front Immunol       Date:  2016-12-23       Impact factor: 7.561

5.  Inhibitory Effect of Bovine Lactoferrin on Catechol-O-Methyltransferase.

Authors:  Masayuki Ikeda; Hiroshi Iijima; Ichizo Shinoda; Hiroshi Iwamoto; Yasuhiro Takeda
Journal:  Molecules       Date:  2017-08-19       Impact factor: 4.411

6.  Tamm-Horsfall glycoprotein enhances PMN phagocytosis by binding to cell surface-expressed lactoferrin and cathepsin G that activates MAP kinase pathway.

Authors:  Syue-Cian Siao; Ko-Jen Li; Song-Chou Hsieh; Cheng-Han Wu; Ming-Chi Lu; Chang-Youh Tsai; Chia-Li Yu
Journal:  Molecules       Date:  2011-03-03       Impact factor: 4.411

7.  A Novel Murine Anti-Lactoferrin Monoclonal Antibody Activates Human Polymorphonuclear Leukocytes through Membrane-Bound Lactoferrin and TLR4.

Authors:  Xiao-Min Hu; Yan-Rui Xu; Ru Yan; Shu-Liang Sun; Hong-Liang Dong; Jun Wang; Xiao-Ming Gao
Journal:  Biomed Res Int       Date:  2015-11-15       Impact factor: 3.411

Review 8.  Lactoferrin: A Critical Player in Neonatal Host Defense.

Authors:  Sucheta Telang
Journal:  Nutrients       Date:  2018-09-04       Impact factor: 5.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.